Molecular cloning and functional analysis of a novel oncogene, cancer-upregulated gene 2 (CUG2)

Biochemical and Biophysical Research Communications

Volumn 360, Issue 3, 2007, Pages 633-639

  Lee, Soojin ^a   Gang, Jingu ^b   Jeon, Sun Bok ^c   Choo, Seung Ho ^c   Lee, Bogman ^c   Kim, Young Gun ^c   Lee, Yang Soon ^d   Jung, Jinyoung ^a   Song, Si Young ^b   Koh, Sang Seok ^d  

^a Chungnam National University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c LG Chemical Ltd   (South Korea)

^d Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

Anti cancer drug target; Cancer upregulated gene 2; Cloning; Microarray; Nuclear protein; Oncogene; Tumorigenesis

Indexed keywords

CANCER UPREGULATED GENE 2; GENE PRODUCT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EXPRESSED SEQUENCE TAG; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE LOCATION; GENE REPRESSION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MALE; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; TUMOR BIOPSY;

ANIMALS; CELL LINE; CELL NUCLEUS; CLONING, MOLECULAR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, NUDE; MOLECULAR SEQUENCE DATA; NEOPLASMS; ONCOGENES; RECOMBINANT FUSION PROTEINS; TRANSFECTION; UP-REGULATION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MUS MUSCULUS;

EID: 34447291385     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.06.102     Document Type: Article

References (17)

1. Vogelstein B., and Kinzler K.W. Cancer genes and the pathways they control. Nat. Med. 10 (2004) 789-799
2. Varmus H.E. Oncogenes and transcriptional control. Science 238 (1987) 1337-1339
3. Butte A. The use and analysis of microarray data. Nat. Rev. Drug Discov. 1 (2002) 951-960
4. Clarke P.A., te Poele R., Wooster R., and Workman P. Gene expression microarray analysis in cancer biology, pharmacology, and drug development: progress and potential. Biochem. Pharmacol. 62 (2001) 1311-1336
5. Darnell Jr. J.E. Transcription factors as targets for cancer therapy. Nat. Rev. Cancer 2 (2002) 740-749
6. Inostroza J.A., Mermelstein F.H., Ha I., Lane W.S., and Reinberg D. Dr1, a TATA-binding protein-associated phosphoprotein and inhibitor of class II gene transcription. Cell 70 (1992) 477-489
7. Geisberg J.V., Holstege F.C., Young R.A., and Struhl K. Yeast NC2 associates with the RNA polymerase II preinitiation complex and selectively affects transcription in vivo. Mol. Cell Biol. 21 (2001) 2736-2742
8. Poon I.K., and Jans D.A. Regulation of nuclear transport: central role in development and transformation?. Traffic 6 (2005) 173-186
9. Bradley M.O., Kraynak A.R., Storer R.D., and Gibbs J.B. Experimental metastasis in nude mice of NIH 3T3 cells containing various ras genes. Proc. Natl. Acad. Sci. USA 83 (1986) 5277-5281
10. Barr S.M., and Johnson E.M. Ras-induced colony formation and anchorage-independent growth inhibited by elevated expression of Puralpha in NIH3T3 cells. J. Cell Biochem. 81 (2001) 621-638
11. Karamouzis M.V., Gorgoulis V.G., and Papavassiliou A.G. Transcription factors and neoplasia: vistas in novel drug design. Clin. Cancer Res. 8 (2002) 949-961
12. Emery J.G., Ohlstein E.H., and Jaye M. Therapeutic modulation of transcription factor activity. Trends Pharmacol. Sci. 22 (2001) 233-240
13. Redell M.S., and Tweardy D.J. Targeting transcription factors for cancer therapy. Curr. Pharm. Des. 11 (2005) 2873-2887
14. Tsutsumi S., Hogan V., Nabi I.R., and Raz A. Overexpression of the autocrine motility factor/phosphoglucose isomerase induces transformation and survival of NIH-3T3 fibroblasts. Cancer Res. 63 (2003) 242-249
15. Nagase T., Kawata S., Nakajima H., Tamura S., Yamasaki E., Fukui K., Yamamoto K., Miyagawa J., Matsumura I., Matsuda Y., and Matsuzawa Y. Effect of farnesyltransferase overexpression on cell growth and transformation. Int. J. Cancer 80 (1999) 126-133
16. Hauck C.R., Hsia D.A., Puente X.S., Cheresh D.A., and Schlaepfer D.D. FRNK blocks v-Src-stimulated invasion and experimental metastases without effects on cell motility or growth. EMBO J. 21 (2002) 6289-6302
17. Willy P.J., Kobayashi R., and Kadonaga J.T. A basal transcription factor that activates or represses transcription. Science 290 (2000) 982-985